Body mass index influences infliximab post-infusion levels and correlates with prospective loss of response to the drug in a cohort of inflammatory bowel disease patients under maintenance therapy with Infliximab

INTRODUCTION: Infliximab is an effective treatment for inflammatory bowel disease (IBD). Studies differ regarding the influence of body mass index (BMI) on the response to infliximab, with the majority of studies indicating that increased BMI may be associated with a poorer response to Infliximab. H...

Descripción completa

Detalles Bibliográficos
Autores principales: Scaldaferri, Franco, D‘Ambrosio, Daria, Holleran, Grainne, Poscia, Andrea, Petito, Valentina, Lopetuso, Loris, Graziani, Cristina, Laterza, Lucrezia, Pistone, Maria Teresa, Pecere, Silvia, Currò, Diego, Gaetani, Eleonora, Armuzzi, Alessandro, Papa, Alfredo, Cammarota, Giovanni, Gasbarrini, Antonio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2017
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5657978/
https://www.ncbi.nlm.nih.gov/pubmed/29073159
http://dx.doi.org/10.1371/journal.pone.0186575

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5657978/
https://www.ncbi.nlm.nih.gov/pubmed/29073159
http://dx.doi.org/10.1371/journal.pone.0186575

Ejemplares similares